Results 101 to 110 of about 330,013 (228)
Background Although vascular dementia (VaD) is not uncommon in the hospital, most studies on VaD are community based. This study on VaD is the first to use a national hospital information system (HIS) in China.Methods This study was a hospital population-
Yongjun Wang+4 more
doaj +1 more source
D054 Visit (VAd) and medication adherence (MAd) in the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): Effect of age and other factors [PDF]
NWACHUKU
openalex +1 more source
Sjuttonhundratalets vetenskap – vad hände och vad händer?
This essay documents the historiography of 18th century Swedish science and its main organizers Johan Nordström and his successor as professor of history of science and ideas at Uppsala University Sten Lindroth, active within this discipline until 1979.
Gunnar Broberg
doaj
Utomhuspedagogik : vad motiverar, vad hindrar pedagogerna?
Validerat; 20101217 (root)
Knutsson, Anna, Laestadius, Catarina
openaire +1 more source
Vascular dementia (VaD) is the second leading cause of dementia after Alzheimer’s disease (AD). In comparison to AD, there is a decline in the incidence of VaD due to recent improvements in cardiovascular risk factors. Brain hypoperfusion and hypoxia due
Jeffrey Chen+6 more
doaj +1 more source
High serum lactate dehydrogenase level predicts short survival after vincristine–doxorubicin–dexamethasone (VAD) salvage for refractory multiple myeloma [PDF]
Miyuki Suguro+8 more
openalex +1 more source
This study explores whether molecular hydrogen (H2) administration can alleviate cognitive and immunological disturbances in a mouse model of vascular dementia (VaD).
Dain Lee, Hyunjun Jo, Jong-Il Choi
doaj +1 more source
First Clinical Experience With the DeBakey VAD Continuous-Axial-Flow Pump for Bridge to Transplantation [PDF]
Georg Wieselthaler+7 more
openalex +1 more source
Changes in adiponectin system after ventricular assist device in pediatric heart failure
Background: Ventricular assist device (VAD) implant represents a therapeutic option for pediatric patients with end-stage heart failure (HF). Heart unloading by VAD can modify several molecular pathways underlying cardiac function in HF.
Rosetta Ragusa+7 more
doaj +1 more source